New York State Common Retirement Fund’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-600
Closed -$588 3308
2025
Q1
$588 Hold
600
﹤0.01% 3168
2024
Q4
$936 Hold
600
﹤0.01% 3170
2024
Q3
$2.2K Sell
600
-30,600
-98% -$107K ﹤0.01% 3167
2024
Q2
$103K Buy
+31,200
New +$131K ﹤0.01% 2769
2022
Q3
Sell
-108
Closed 3414
2022
Q2
$0 Sell
108
-6,277
-98% -$16.7K ﹤0.01% 3524
2022
Q1
$26K Buy
6,385
+108
+2% +$789 ﹤0.01% 3270
2021
Q4
$69K Buy
+6,277
New +$71.9K ﹤0.01% 3162

Other funds holding PYXS

New York State Common Retirement Fund's PYXS Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 600 shares — an estimated $588 sold.

New York State Common Retirement Fund first reported a position in PYXS in Q4 2021 and held it in 7 quarters. The position peaked at $103K in Q2 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 600 Pyxis Oncology shares in Q2 2025, an estimated $588.
  • New York State Common Retirement Fund first reported a position in Pyxis Oncology in Q4 2021 and held it in 7 quarters.
  • New York State Common Retirement Fund's Pyxis Oncology position peaked at $103K in Q2 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.